Kaken Pharmaceutical Co., Ltd. (4521.T)

Home
4521.T
Financials

3901 (JPY) • At close September 19, 2024

Overview | Financials

Numbers are in millions (except for per share data and ratios) JPY.

	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010	2009	2008	2007	2006	2005	2004
Assets:
Current Assets:
Cash & Cash Equivalents Numbers are in millions	65,324	59,561	61,025	63,706	59,722	46,956	45,095	33,867	29,845	10,553	9,644	9,710	9,543	14,729	9,900	10,155	8,288	10,915	9,681	17,271
Short Term Investments Numbers are in millions	14,699	14,699	13,599	13,599	13,599	11,599	7,599	9,899	11,899	14,214	7,812	7,210	8,308	2,305	7,603	2,401	4,097	999	149	149
Cash and Short Term Investments Numbers are in millions	65,324	74,260	74,624	77,305	73,321	58,555	52,694	43,766	41,744	24,767	17,456	16,920	17,851	17,034	17,503	12,556	12,385	11,914	9,830	17,420
Net Receivables Numbers are in millions	23,744	19,268	20,260	20,549	21,800	30,340	34,510	29,159	31,546	29,546	26,490	32,291	33,142	28,297	28,828	29,666	29,235	35,762	33,361	34,850
Inventory Numbers are in millions	17,167	15,563	14,980	15,197	12,274	13,719	16,651	16,495	14,506	13,482	13,220	11,531	10,924	10,299	8,992	10,945	9,938	9,126	9,657	10,249
Other Current Assets Numbers are in millions	739	812	749	611	941	1,117	1,200	1,074	1,195	1,221	1,335	1,241	1,297	1,255	1,501	1,764	1,645	1,798	2,408	1,611
Total Current Assets Numbers are in millions	106,974	109,903	110,613	113,662	108,336	103,731	105,055	90,494	88,991	69,016	58,501	61,983	63,214	56,885	56,824	54,931	53,203	58,600	55,256	64,130
Non-Current Assets:
Property, Plant & Equipment, Net Numbers are in millions	25,355	25,498	25,734	25,020	25,518	26,402	26,141	26,271	26,726	25,961	28,516	29,138	28,368	28,148	25,243	25,895	25,151	25,237	25,435	26,402
Goodwill Numbers are in millions	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Intangible Assets Numbers are in millions	7,462	6,741	8,236	625	414	551	552	372	371	474	598	732	966	396	391	448	495	485	298	271
Goodwill and Intangible Assets Numbers are in millions	7,462	6,741	8,236	625	414	551	552	372	371	474	598	732	966	396	391	448	495	485	298	271
Long Term Investments Numbers are in millions	20,532	20,312	18,871	22,447	20,376	22,365	10,889	6,044	2,501	1,143	3,182	3,062	-1,886	3,774	-2,158	2,641	3,636	9,392	11,121	6,693
Tax Assets Numbers are in millions	2,590	3,873	1,725	1,577	3,229	2,934	426	887	1,319	3,226	5,588	4,448	4,899	5,220	4,900	5,276	4,221	3,413	3,467	6,500
Other Non-Current Assets Numbers are in millions	8,710	-1	-1	-1	-2	-2	9,352	10,990	13,080	15,311	10,077	9,545	9,547	4,070	9,896	5,313	7,150	3,773	3,162	4,551
Total Non-Current Assets Numbers are in millions	64,649	56,423	54,565	49,668	49,535	52,250	47,360	44,564	43,997	46,115	47,961	46,925	41,894	41,608	38,272	39,573	40,653	42,300	43,483	44,417
Total Assets Numbers are in millions	171,623	166,328	165,181	163,332	157,875	155,985	152,417	135,060	132,991	115,135	106,465	108,911	105,108	98,493	95,096	94,504	93,856	100,900	98,739	108,547
Liabilities & Equity:
Current Liabilities:
Account Payables Numbers are in millions	7,099	6,130	5,861	8,425	7,720	10,729	12,204	9,854	12,256	12,295	13,713	16,367	21,341	16,381	14,626	17,414	16,698	4,317	3,488	3,140
Short Term Debt Numbers are in millions	3,850	3,850	3,850	3,850	3,850	3,875	3,875	3,875	5,007	5,572	4,349	8,592	8,544	8,567	8,640	8,341	8,707	6,386	5,422	5,448
Tax Payables Numbers are in millions	76	2,004	2,436	2,292	2,904	4,042	5,097	3,049	8,628	3,807	3,628	2,850	3,784	3,793	2,557	2,879	2,255	2,829	310	2,480
Deferred Revenue Numbers are in millions	43	9,389	7,373	7,049	7,733	9,664	5,097	8,347	15,069	10,894	9,467	9,972	6,230	6,293	5,369	5,254	4,568	20,373	15,099	18,015
Other Current Liabilities Numbers are in millions	8,032	1,469	1,965	1,952	2,352	3,312	10,225	1,944	1,529	1,608	527	301	239	225	223	228	309	402	245	416
Total Current Liabilities Numbers are in millions	19,024	20,838	19,049	21,276	21,655	27,580	31,401	24,020	33,861	30,369	28,056	35,232	36,354	31,466	28,858	31,237	30,282	31,478	24,254	27,019
Non-Current Liabilities:
Long Term Debt Numbers are in millions	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	3,000	13,192	20,394
Deferred Revenue Non-Current Numbers are in millions	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	5,312	6,034	14,952
Deferred Tax Liabilities Non-Current Numbers are in millions	1,947	1,771	2,229	2,284	1,493	2,121	2,563	0	0	121	135	142	150	179	189	200	210	220	239	259
Other Non-Current Liabilities Numbers are in millions	6,895	6,884	5,580	3,516	6,260	5,154	4,580	8,386	9,256	7,547	10,180	6,960	6,533	6,473	6,474	6,388	5,917	461	383	433
Total Non-Current Liabilities Numbers are in millions	8,842	8,655	7,809	5,800	7,753	7,275	7,143	8,386	9,256	7,668	10,315	7,102	6,683	6,652	6,663	6,588	6,127	8,993	19,848	36,038
Total Liabilities Numbers are in millions	27,866	29,493	26,858	27,076	29,408	34,855	38,544	32,406	43,117	38,037	38,371	42,334	43,037	38,118	35,521	37,825	36,409	40,471	44,102	63,057
Equity:
Preferred Stock Numbers are in millions	0	131,368	132,893	131,418	126,755	117,536	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Common Stock Numbers are in millions	23,853	23,853	23,853	23,853	23,853	23,853	23,853	23,853	23,853	23,853	23,853	23,853	23,853	23,853	23,853	23,853	23,853	23,348	20,737	17,127
Retained Earnings Numbers are in millions	128,506	126,135	126,347	122,462	114,869	109,057	97,284	84,331	68,609	52,932	49,789	43,997	38,672	33,806	28,684	24,698	21,440	18,305	15,428	12,859
Accumulated Other Comprehensive Income/Loss Numbers are in millions	8,547	4,889	4,852	4,838	1,712	3,594	4,587	2,877	2,306	5,006	522	1,937	0	0	0	0	0	0	0	0
Other Total Stockholders Equity Numbers are in millions	-17,151	-149,988	-150,200	-146,315	-138,722	-132,910	-11,851	-8,407	-4,894	-4,693	-6,070	-3,210	-454	2,716	7,038	8,128	12,154	18,776	18,472	15,504
Total Shareholders Equity Numbers are in millions	143,755	136,257	137,745	136,256	128,467	121,130	113,873	102,654	89,874	77,098	68,094	66,577	62,071	60,375	59,575	56,679	57,447	60,429	54,637	45,490
Total Equity Numbers are in millions	143,755	136,835	138,323	136,256	128,467	121,130	113,873	102,654	89,874	77,098	68,094	66,577	62,071	60,375	59,575	56,679	57,447	60,429	54,637	45,490
Total Liabilities & Shareholders Equity Numbers are in millions	171,621	166,328	165,181	163,332	157,875	155,985	152,417	135,060	132,991	115,135	106,465	108,911	105,108	98,493	95,096	94,504	93,856	100,900	98,739	108,547

Kaken Pharmaceutical Co., Ltd.

TSE:4521.T Add to watchlist

TSE:4521.T